Categories Earnings, Health Care, LATEST

PetMed (PETS) Q3 earnings drop but beat Street view; sales miss

Earnings of PetMed Express Inc. (NASDAQ: PETS) decreased in the third quarter even as net sales remained unchanged. The bottom line, however, exceeded the market’s expectations.

Net income dropped to $6.8 million or $0.34 per share in the third quarter from $7.7 million or $0.38 per share a year earlier. Earnings, however, exceeded analysts’ forecast. At $59.9 million, net sales were broadly flat year-over-year but below the market’s expectations.

Order Growth

During the three-month period, the average order size edged up to $85 from $84 last year. Reorder sales increased 1% annually to $53.8 million.

Related: PetMed Q2 Earnings Conference Call Transcript

The management’s successful efforts to establish direct purchasing relationships with leading manufacturers and the implementation of minimum advertised price policy have translated into margin growth. Total operating expenses decreased 2% to $9.8 million.

Competition

Of late, the company has been focused on marketing and promotional activities as it continues to face stiff competition from rival pet pharmacy Chewy (CHWY). Last month, Chewy reported a net loss for its third quarter, despite an increase in sales. The bottom line was impacted by higher operating expenses.

“In 2020, we will focus on optimizing our marketing in this more competitive environment and being more efficient with our advertising spending. In addition, we will continue investing in our e-commerce platform to better service our customers. This platform will enable us to improve upon our already strong net promoter score of 84.0%.“ said PetMed’s CEO Menderes Akdag.

Dividend

In the third quarter, PetMed’s board of directors declared a quarterly cash dividend of $0.27 per share, which will be paid on February 14, 2020, to shareholders of record on February 3, 2020.

Also read: Retail space gets busy as firms see new opportunities

Last week, PetMed shares climbed to the highest level in twelve months. The stock closed the last trading session notably higher but traded lower during Tuesday’s premarket trading hours. Since the beginning of the year, it gained about 17%.

Listen to publicly listed companies’ earnings conference calls along with the edited closed caption text

Most Popular

CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q2 2024 financial results

Colgate-Palmolive Company (NYSE: CL) reported its second quarter 2024 earnings results today. Net sales increased 4.9% year-over-year to $5 billion. Organic sales increased 9%. Net income attributable to Colgate-Palmolive Company was $731

Key takeaways from Visa’s Q3 2024 earnings report

Credit card behemoth Visa, Inc. (NYSE: V) this week reported mixed results for the June quarter, with earnings matching expectations and sales slightly missing the view. Both numbers grew in

Southwest Airlines (LUV): A look at the airline’s performance in Q2 2024

Shares of Southwest Airlines Co. (NYSE: LUV) were up over 6% on Thursday after the company beat earnings estimates for the second quarter of 2024. The stock has gained 4%

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top